Liftstream is an executive search recruitment company in the life sciences sector
10 companies driving forward the rare disease market
Authored by Liftstream
Posted in Orphan Drugs and Rare Diseases
Tagged Aegerion, Amicus Therapeutics, Duchenne Muscular Dystrophy, Liftstream Rare Disease Day, Oxyrane, Promethera, Prosensa, PTC Therapeutics, Rare Disease, Rare Disease Day 2013, Sangart, Sarepta Therapeutics, Synageva, Ultragenyx, White Paper, world orphan drug congress
Leave a comment
Sarepta’s hopes high for first Duchenne (DMD) therapy
Authored by James Sheppard
Posted in Orphan Drugs and Rare Diseases
Tagged AVI Biopharma, AVI-7100, Department of Defense, DMD, Duchenne Muscular Dystrophy, Ebola, EMEA, Eteplirsen, exon skipping, FDA, Infectious Disease, Influenza, Liftstream Rare Disease Day, Marburg Virus, NIH Clinical Center in Bethesda, Phase II Trials, PMO Chemistry, Rare Disease Day 2013, RDD13, Sarepta Therapeutics, UCL, University College London, USA
Leave a comment
Amicus Therapeutics looking to bounce back in 2013
Authored by Paul Foster
Posted in Orphan Drugs and Rare Diseases
Tagged Alzheimer's Drug Discovery Foundation, Amicus Therapeutics, Amigal, ERT, Fabry Disease, Gaucher Disease, GlazoSmithKline, Liftstream Rare Disease Day, LSDs, Lysosomal Storage Disorders, Michael J Fox Foundation, New Jersey, Parkinsons's, Pharmacological Chaperones, Pompe Disease, Rare Disease, Rare Disease Day 2013, RDD13, San Diego
Leave a comment